# PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS

> **NCT04104451** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 16 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Corlicyte

## Key facts

- **NCT ID:** NCT04104451
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-12
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04104451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04104451, "PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04104451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*